BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6975992)

  • 1. [Classification of acute leukemias by surface markers and correlation with the morphological diagnosis. Results of 111 cases].
    von Fliedner V; Carrel S; Morell A; Heumann D; Losa G; Hirt A; Jeannet M; Mach JP; Cruchaud A
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1524-6. PubMed ID: 6975992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
    Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
    Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunophenotypic analysis in acute leukemia].
    Akashi K; Harada M
    Nihon Rinsho; 1992 Jun; 50(6):1229-35. PubMed ID: 1518138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
    Piedras J; Barrales-Benítez O; López-Karpovitch X
    Rev Invest Clin; 2000; 52(5):524-8. PubMed ID: 11195181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of monoclonal antibodies in the diagnosis of acute leukemia].
    Pönisch W; Friedrich T; Leiblein S; Siebert M
    Acta Histochem Suppl; 1988; 35():193-7. PubMed ID: 3138715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of human leukemia by membrane antigen analysis with xenoantisera.
    Metzgar RS; Dowell BL; Lachman LB; Jones NH; George FW
    Cancer Res; 1981 Nov; 41(11 Pt 2):4781-85. PubMed ID: 6794906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface markers in acute lymphoblastic leukemia.
    Humphrey GB; Blackstock R; Filler J
    Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of lineage specific differentiation markers for complex classification of acute leukemias. II. Acute lymphoblastic leukemias.
    Lemez P
    Neoplasma; 1990; 37(3):267-81. PubMed ID: 2196472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical perspective on cell markers in acute lymphocytic leukemia.
    Bowman WP; Melvin SL; Aur RJ; Mauer AM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
    Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
    Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping in the diagnosis and classification of acute lymphoblastic leukemia.
    Sobol RE; Bloomfield CD; Royston I
    Clin Lab Med; 1988 Mar; 8(1):151-62. PubMed ID: 3282757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.